Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

5.700 -0.090 (-1.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Treace Medical Concepts, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. 
Via Benzinga
The Latest Analyst Ratings for Treace Medical Concepts
 
Via Benzinga
Analyst Ratings for Treace Medical Concepts
 
Via Benzinga
What 5 Analyst Ratings Have To Say About Treace Medical Concepts
 
Via Benzinga
Treace to Present at Stifel 2023 Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Third Quarter 2023 Financial Results
Company to Host Conference Call on Thursday, November 9, 2023 at 4:30 pm ET 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Looking Into Treace Medical Concepts's Return On Capital Employed
 
Via Benzinga
Treace Medical Concepts's Earnings Outlook
 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 369 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 386 stocks made new 52-week lows. 
Via Benzinga
Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Participation in the 21st Annual Morgan Stanley Global Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 225 companies set new 52-week lows. 
Via Benzinga
Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 283 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 128 companies set new 52-week lows. 
Via Benzinga
Treace Medical Concepts Reports Second Quarter 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Participation in the UBS Medtech, Tools and Genomics Summit 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Second Quarter 2023 Financial Results on August 8, 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Appoints Julie Dewey as Chief Communications and Investor Relations Officer
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Completes Acquisition of Technology Enabling Patient Specific Instrumentation and Reports on Clinical Cases Using PSI with the Lapiplasty® System
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle Surgeries
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports First Quarter 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Earnings Scheduled For May 8, 2023
Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
 
Via Benzinga
Treace Announces Participation in the Bank of America 2023 Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.